Defining Musical Toxicity and Its Effect on Patient Well-being
This study evaluates the experience of musicians who are going through cancer treatment.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Jun 4, 2025 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Observational
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Mayo Clinic
- Interventions being studied
- Other: Non-Interventional Study
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- \
- Adults ≥ 18 years or older
- Active or accomplished musicians
- Those performing in the community as part of a group or as a soloist
- Those teaching lessons in an individual or group setting
- Those for whom music teaching or performance is a primary source of income
- Those who play music multiple times per week
- Our ideal cohort will consist of an equal number of patients with the following malignancies above the diaphragm:
- Brain
- Head and Neck
- Esophagus or Lung
- Breast
- Our ideal cohort will consist of an equal number of patients who engage in the following musical endeavors:
- Stringed instruments
- Wind instruments (including woodwind and brass instruments)
- Keyboard instruments
- Vocalists
- \
- \< 18 years
- Did not regularly attempt to engage in musical endeavors during or after cancer treatment
- Not willing or able to complete the questionnaire or engage in a one-hour interview (i.e. limited English proficiency)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Mayo Clinic in RochesterRochester, Minnesota
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 4, 2025. Always confirm current availability with the study team.